Biogen Realized Investment Gains (Losses) increased by 686.8% to $22.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 162.6%, from -$35.60M to $22.30M.
isrg_realized_investment_gains_losses| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $153.90M | -$424.50M | -$191.10M | -$78.20M | $101.80M | -$77.70M | $105.40M | -$317.30M | -$30.60M | -$30.70M | $39.10M | -$35.60M | $5.30M | -$3.80M | $22.30M |
| QoQ Change | — | -375.8% | +55.0% | +59.1% | +230.2% | -176.3% | +235.6% | -401.0% | +90.4% | -0.3% | +227.4% | -191.0% | +114.9% | -171.7% | +686.8% |
| YoY Change | — | — | — | -150.8% | +124.0% | +59.3% | +234.8% | -411.7% | +60.6% | -129.1% | +112.3% | -16.3% | +117.3% | -109.7% | +162.6% |